Sunday, May 29, 2011

Stress Signals in Cancer Cells


Stress Signal in Cancer Cells
Triggers Similar Response in
Other Cells, Potentially Aiding
Tumor Growth

Man Under StressResearchers at the University of
California, San Diego School of
Medicine demonstrate how a
"stress response" mechanism
used by normal cells to cope
with harsh or demanding conditions
is exploited by cancer cells, which
transmit the same stress signal to
surrounding cells, triggering an
inflammatory response in them
that can aid tumor growth.
The findings are reported by Maurizio Zanetti, MD,
professor of medicine and director of the Laboratory
of Immunology at the UC San Diego Moores Cancer
Center, and colleagues, and published in the April
online edition of Proceedings of the National Academy
of Sciences.
The endoplasmic reticulum (ER) is the protein-making
factory inside all cells. Increased physiological demands
or disease conditions can sometimes cause proteins to
misfold and accumulate in the ER. Cells typically
respond by an ER stress response, which attempts
to reset normal ER balance.
For normal cells, the ER stress response is transient. For
tumor cells, it's life. Because they exist in an environment
that's invariably difficult (their host is always trying to kill
them, and oxygen and nutrient deprivation are frequent),
tumor cells produce an on-going ER stress response,
which helps them to thrive.
According to the researchers, tumor cells generate
"transmissible ER stress." Specifically, they induce
bystander cells to issue a similar stress response,
most notably nearby macrophages, a type of white
blood cell employed by the body's immune system to
recognize and remove pathogens and cellular debris.
Recently, several laboratories, including UC San Diego,
have underscored the crucial role of inflammation in
promoting cancer growth. A consequence of
"transmissible ER stress" points to "receiver"
macrophages as an important source of inflammation,
which serves as an environmental cue for cancer development.
"It's well-known that macrophages entering the tumor
microenvironment lose the ability to aid the immune
system in rejecting the tumor, and that they may actually
play a role in actively suppressing anti-tumor immunity,"
said the scientists working in the study. "We believe that
transmissible ER stress could be an important initial
tumor-derived signal that promotes the 'brainwashing' of
macrophages in the tumor microenvironment. It could be
the first event in a cascade that results in the
commandeering of macrophages by the tumor."
If so, transmissible ER stress may represent a unifying
mechanism that explains at least some of the earliest
interactions between tumors and the immune system.
"Our paper details the first evidence of this
phenomenon," they said, adding that transmissible ER
stress also presents a new, potential target for tumor-
specific therapies and drugs.
"Our findings suggest that development of therapies
targeted against the tumor ER stress response may
be doubly effective," they added. "Such therapies would
target not only the tumor's intrinsic ability to cope with
micro-environmental insults, but, at the same time,
would impede the tumor cells' ability to nullify the anti-
tumor immune response, perhaps allowing our bodies
to more easily fight off tumors."
Co-authors of the study are Navin R. Mahadevan and
Jeffrey Rodvold, Laboratory of Immunology UC San
Diego Moores Cancer Center and Biomedical Sciences
Program; Homero Sepulveda, BD Biosciences, San
Diego; Steven Rossi, UCSD Department of Pediatrics,
Cancer Symptom Control Program; and Angela F. Drew,
Department of Cancer and Cell Biology, University of
Cincinnati.
Funding for this research came,from grants from the
UCSD Academic Senate, UCSD Medical Scientist
Training Program and the National Institute on Drug
Abuse.
Story Source: University of California - San Diego.
Journal Reference:
Navin R. Mahadevan, Jeffrey Rodvold, Homero
Sepulveda, Steven Rossi, Angela F. Drew, Maurizio
Zanetti. Transmission of endoplasmic reticulum stress
and pro-inflammation from tumor cells to myeloid cells.
Proceedings of the National Academy of Sciences, 2011;
Editor's Note: This article is not intended to provide medical advice,
diagnosis or treatment.

0 comments:

Post a Comment